Oral application of magnesium‐L‐threonate enhances analgesia and reduces the dosage of opioids needed in advanced cancer patients—A randomized, double‐blind, placebo‐controlled trial

PURPOSE: To investigate the effects of oral administration of magnesium‐L‐threonate, a novel magnesium compound, on the analgesic effect of opioids in patients with advanced cancer. METHODS: We performed a prospective, randomized, double‐blind trial at a tertiary hospital in Shanghai, China. Eligibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Siyin, Jin, Tian, Ma, Bingjie, Ji, Yun, Huang, Xuehua, Wang, Peiliang, Liu, Xiaoming, Krylov, Boris V., Liu, Xianguo, Ma, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972038/
https://www.ncbi.nlm.nih.gov/pubmed/36703238
http://dx.doi.org/10.1002/cam4.4922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972038/
https://www.ncbi.nlm.nih.gov/pubmed/36703238
http://dx.doi.org/10.1002/cam4.4922

Ejemplares similares